Clinical trial
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck…
NCT00005088 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005088 |
|---|---|
| Title | Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer |
| Official title | A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, radiation therapy |
| Start date | Apr 1, 2000 |
| Primary completion | Jan 1, 2002 |
| First posted | May 26, 2004 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: